Vasiliki Michalarea
Guy's And St Thomas' NHS Foundation Trust
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 15, 2023
Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 18, 2023
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 06, 2022
The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre.
Journal: Cancers
Published: August 20, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage.
Journal: Nature communications
Published: October 06, 2020
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant Cancers.
Journal: Cancer discovery
Published: February 15, 2020
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells.
Journal: Hepatology (Baltimore, Md.)
Published: July 31, 2019
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours.
Journal: British journal of cancer
Published: June 06, 2019
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 03, 2019
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 15, 2019
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review.
Journal: Current problems in cancer
Published: November 12, 2018
Neoadjuvant DCF vs. ACF for resectable oesophageal squamous cell carcinoma.
Journal: Journal of thoracic disease
Published: December 10, 2017
Last Updated: 09/26/2026